Isabelle Bernard-Pierrot Selected Research

Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)

10/2013

Integrative modelling of the influence of MAPK network on cancer cell fate decision.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Bernard-Pierrot Research Topics

Disease

17	Urinary Bladder Neoplasms (Bladder Cancer) 06/2023 - 01/2011
15	Neoplasms (Cancer) 06/2023 - 08/2002
6	Carcinoma (Carcinomatosis) 01/2023 - 01/2004
5	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2002
3	Breast Neoplasms (Breast Cancer) 03/2014 - 09/2008
2	Non-Muscle Invasive Bladder Neoplasms 06/2023 - 01/2023
2	Carcinogenesis 01/2023 - 08/2002
1	Ureteral Neoplasms (Ureteral Cancer) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Tertiary Lymphoid Structures 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Virus Diseases (Viral Diseases) 11/2018
1	Adenocarcinoma 11/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 05/2011
1	Neuroblastoma 01/2004
1	Glioma (Gliomas) 01/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 06/2023 - 08/2002
4	Phenobarbital (Luminal)FDA Link 01/2023 - 11/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017 - 08/2002
4	pleiotrophin (HARP)IBA 05/2011 - 08/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2022 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2017
3	ErbB Receptors (EGF Receptor)IBA 10/2015 - 10/2013
3	Heparin (Liquaemin)FDA LinkGeneric 05/2011 - 08/2002
2	LigandsIBA 06/2023 - 09/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2011
2	Phosphotransferases (Kinase)IBA 11/2018 - 09/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 09/2017
2	Small Interfering RNA (siRNA)IBA 03/2014 - 11/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	uridylyl-(3'-5')-guanosineIBA 06/2023
1	CarcinogensIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	VimentinIBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 12/2021
1	ProteomeIBA 01/2021
1	InterferonsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	mesoglycanIBA 12/2020
1	c-Mer Tyrosine KinaseIBA 01/2019
1	Insulin (Novolin)FDA Link 09/2017
1	Growth Factor ReceptorsIBA 09/2017
1	Carrier Proteins (Binding Protein)IBA 09/2017
1	DecorinIBA 12/2013
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 10/2013
1	AntibodiesIBA 01/2013
1	Monoclonal AntibodiesIBA 01/2013
1	IntegrinsIBA 01/2013
1	Blocking AntibodiesIBA 01/2013
1	Peptides (Polypeptides)IBA 05/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2008
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 09/2008
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2004
1	Protein Isoforms (Isoforms)IBA 12/2004
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004
1	MidkineIBA 01/2004
1	N 30IBA 01/2004
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2002
1	Amino Acids FDA Link 08/2002

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2013
2	Radiotherapy 08/2022 - 12/2020
2	Immunotherapy 01/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022
1	Cystectomy 12/2020